Bukari Bakhtiar, Samarasinghe Rasika M, Noibanchong Jinjutha, Shigdar Sarah L
School of Medicine, Deakin University, Geelong, VIC 3216, Australia.
Centre for Molecular and Medical Research, Deakin University, Geelong, VIC 3216, Australia.
Biomedicines. 2020 May 14;8(5):120. doi: 10.3390/biomedicines8050120.
The blood-brain barrier (BBB) is a highly specialised network of blood vessels that effectively separates the brain environment from the circulatory system. While there are benefits, in terms of keeping pathogens from entering the brain, the BBB also complicates treatments of brain pathologies by preventing efficient delivery of macromolecular drugs to diseased brain tissue. Although current non-invasive strategies of therapeutics delivery into the brain, such as focused ultrasound and nanoparticle-mediated delivery have shown various levels of successes, they still come with risks and limitations. This review discusses the current approaches of therapeutic delivery into the brain, with a specific focus on non-invasive methods. It also discusses the potential for aptamers as alternative delivery systems and several reported aptamers with promising preliminary results.
血脑屏障(BBB)是一个高度专业化的血管网络,它有效地将大脑环境与循环系统分隔开来。虽然血脑屏障在防止病原体进入大脑方面有好处,但它也会阻碍大分子药物有效输送到患病脑组织,从而使脑部疾病的治疗变得复杂。尽管目前将治疗药物输送到大脑的非侵入性策略,如聚焦超声和纳米颗粒介导的输送已取得不同程度的成功,但它们仍存在风险和局限性。本综述讨论了目前将治疗药物输送到大脑的方法,特别关注非侵入性方法。它还讨论了适体作为替代输送系统的潜力以及一些报道的具有良好初步结果的适体。